Dexlansoprazole MR-Based Concomitant Quadruple Therapy
Condition:   Helicobacter Pylori Infection Interventions:   Drug: Dexlan;   Drug: Amoxicillin;   Drug: Clarithromycin 500mg;   Drug: Metronidazole Sponsor:   Chang Gung Memorial Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2019 Category: Research Source Type: clinical trials

A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules
Condition:   Healthy Volunteers Interventions:   Drug: 30 mg dexlansoprazole capsules manufactured at TOB;   Drug: 30 mg dexlansoprazole capsules manufactured at TPC;   Drug: 60 mg dexlansoprazole capsules manufactured at TOB;   Drug: 60 mg dexlansoprazole capsules manufactured at TPC Sponsor:   Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2019 Category: Research Source Type: clinical trials